Works matching IS 00912700 AND DT 2022 AND VI 62 AND IP 3

Results: 15

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 285, doi. 10.1002/jcph.1659
Publication type:: Article

2021 JCP Reviewer Thank You List.

Published in:: Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 440, doi. 10.1002/jcph.2028
Publication type:: Article

Response to Letter to the Editor by Dr Robinson.

Published in:

2022

By:

White, C. Michael;
White, Lyla R.

Publication type:

Letter to the Editor

Conflation of Tuskegee Study With FDA Fiduciary Responsibilities Sensationally Ignores International Law.

Published in:

2022

By:

Robinson, Keith

Publication type:

Letter to the Editor

Preventing a New Tuskegee: Food and Drug Administration Oversight of Overseas Research Must Match That in the United States.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 434, doi. 10.1002/jcph.1976

By:

White, C. Michael;
White, Lyla R.

Publication type:

Article

Population Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Kinase Inhibitor, in Patients With Advanced Solid Tumors.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 422, doi. 10.1002/jcph.1974

By:

Xiaofei Zhou;
Ouerdani, Aziz;
Diderichsen, Paul Matthias;
Gupta, Neeraj

Publication type:

Article

Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 409, doi. 10.1002/jcph.1991

By:

Bergstrand, Martin;
Hansson, Emma;
Delaey, Bernard;
Callewaert, Filip;
Sousa, Rui De Passos;
Sargentini-Maier, Maria Laura

Publication type:

Article

Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 397, doi. 10.1002/jcph.1973

By:

Kyunghun Park;
Vishnevetskaya, Kristina;
Vaidyanathan, Jayabharathi;
Burckart, Gilbert J.;
Green, Dionna J.

Publication type:

Article

Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic Modeling.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 385, doi. 10.1002/jcph.1972

By:

Litjens, Carlijn H. C.;
Verscheijden, Laurens F. M.;
Bolwerk, Celine;
Greupink, Rick;
Koenderink, Jan B.;
van den Broek, Petra H. H.;
van den Heuvel, Jeroen J. M. W.;
Svensson, Elin M.;
Boeree, Martin J.;
Magis-Escurra, Cecile;
Hoefsloot, Wouter;
van Crevel, Reinout;
van Laarhoven, Arjan;
van Ingen, Jakko;
Kuipers, Saskia;
Ruslami, Rovina;
Burger, David M.;
Russel, Frans G. M.;
Aarnoutse, Rob E.;
te Brake, Lindsey H. M.

Publication type:

Article

Pharmacodynamic Modeling of CDK4/6 Inhibition-Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression-Free Survival in Patients With Advanced Breast Cancer.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 376, doi. 10.1002/jcph.1971

By:

Yanke Yu;
Wan Sun;
Yuan Liu;
Diane Wang

Publication type:

Article

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 366, doi. 10.1002/jcph.1970

By:

Yukihiro Chino;
Masanari Kuwabara;
Ichiro Hisatome

Publication type:

Article

Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 359, doi. 10.1002/jcph.1967

By:

Yoonsun Mo;
Shcherbakova, Natalia;
Inman, Kelsey L.;
Wai Kin Li;
Kovalenko, Kateryna;
Rosenberg, Joshua;
Orsini, Jose;
Truong, James

Publication type:

Article

Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 320, doi. 10.1002/jcph.1988

By:

Manolis, Antonis A.;
Manolis, Theodora A.;
Melita, Helen;
Mikhailidis, Dimitri P.;
Manolis, Antonis S.

Publication type:

Article

Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical Equations.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 304, doi. 10.1002/jcph.1989

By:

Yoko Franchetti

Publication type:

Article

Neurological Immune-Related Adverse Events After COVID-19 Vaccination: A Systematic Review.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 291, doi. 10.1002/jcph.2017

By:

Shafiq, Ameena;
Salameh, Mohammad A.;
Laswi, Ibrahim;
Mohammed, Ibrahim;
Mhaimeed, Omar;
Mhaimeed, Nada;
Mhaimeed, Narjis;
Paul, Pradipta;
Mushannen, Malik;
Elshafeey, Abdallah;
Fares, Ahmed;
Holroyd, Sean;
Zakaria, Dalia

Publication type:

Article